[The effect of alkylating cytostatics on the development of secondary malignant tumors].
作者信息
Galajda P, Donner L
出版信息
Vnitr Lek. 1984 Aug;30(8):756-63.
PMID:6506498
Abstract
摘要
相似文献
1
[The effect of alkylating cytostatics on the development of secondary malignant tumors].[烷化剂类细胞抑制剂对继发性恶性肿瘤发生发展的影响]
Vnitr Lek. 1984 Aug;30(8):756-63.
2
An overview of the status of the nitrosoureas in other tumors.亚硝基脲类药物在其他肿瘤中的应用现状综述。
Cancer Chemother Rep 3. 1973 May;4(3):35-46.
3
[Polychemotherapy of malignant tumors and hemoblastoses].[恶性肿瘤和血液病的多药化疗]
Wien Z Inn Med. 1968;49(12):449-61.
4
[Secondary malignant neoplasms and cytostatic therapy].[继发性恶性肿瘤与细胞抑制疗法]
Lebensversicher Med. 1982 Jun 14;34(5):110-3.
5
[Internal medicine therapy of malignant lymphomas].[恶性淋巴瘤的内科治疗]
Ergeb Inn Med Kinderheilkd. 1976;38:1-35.
6
[Cytostatic therapy of hemoblastosis].
Pharmakotherapia. 1964;2(1):59-88.
7
[Secondary tumors following cytostatic chemotherapy with alkylating agents in man; the toxicological viewpoints].[人类使用烷化剂进行细胞抑制化疗后的继发性肿瘤；毒理学观点]
Dtsch Med Wochenschr. 1986 May 23;111(21):833-5. doi: 10.1055/s-2008-1068542.
8
[Current therapy of malignant blood diseases].[恶性血液病的当前治疗方法]
Praxis. 1967 Jun 29;56(26):901-6.
9
Second malignancies and chemotherapeutic agents.第二原发性恶性肿瘤与化疗药物。
Prog Clin Biol Res. 1983;132E:45-54.
10
[Lithium carbonate in prevention of leukopenia/caused by antineoplastic drugs].[碳酸锂预防抗肿瘤药物引起的白细胞减少症]
G Clin Med. 1981 May;62(5):351-9.
Zotero 插件